Rohit Kulkarni, Roth MKM managing director, joins 'Squawk on the Street' to discuss how the ban of TikTok impacts the social ...

Roth MKM keeps a Buy rating on Imax (IMAX) with a $28 price target after the company signed an exclusive, worldwide deal with ...

Stock Trading Recap. On Friday, Reviva Pharmaceuticals Holdings Inc (RVPH) stock saw a decline, ending the day at $1.77 which represents ...

In a report released today, Craig Irwin from Roth MKM maintained a Buy rating on Plug Power (PLUG – Research Report), with a price target of ...

Target (NYSE:TGT – Get Free Report) had its price target upped by stock analysts at Truist Financial from $129.00 to $134.00 ...

Roth MKM lowered the firm’s price target on Mattel (MAT) to $20 from $21 and keeps a Neutral rating on the shares ahead of ...

Roth MKM analyst Bill Kirk assigned a Buy rating to High Tide (HITI – Research Report) today and set a price target of $4.50. The company’s ...

Aspen Aerogels (NYSE:ASPN – Free Report) had its price objective trimmed by Canaccord Genuity Group from $28.00 to $20.00 in ...

Atkore Inc (ATKR) stock saw a modest uptick, ending the day at $85.17 which represents a slight increase of $1.72 or 2.06% from the prior close of $83.45. The stock opened at $84.61 and touched a low ...

Roth MKM keeps a Buy rating and $38 price target on Digi International (DGII) following its non-deal roadshow with the management team. The firm comes away from the discussions “cautiously ...

Roth MKM last night initiated coverage of Entrada Therapeutics (TRDA) with a Buy rating and $29 price target Entrada is an early-stage biopharma that seeks to solve a key bottleneck, which is ...